terfenadine has been researched along with betadex in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weems, H; Zamani, K | 1 |
Khalil, SK; Surapaneni, S | 1 |
Choi, HG; Han, JH; Kim, CK; Kim, YB; Lee, BJ; Lee, MK; Park, KM; Rhee, JD; Yong, CS | 1 |
Havránek, E; Mikus, P; Valásková, I | 1 |
Cox, BF; Fischer, C; Gintant, GA; Limberis, JT; Long, MA; Martin, RL; Mikhail, A; Patel, A; Su, Z | 1 |
Balakrishnan, P; Cho, HJ; Chung, SJ; Hong, SS; Jang, TY; Kim, DD; Kim, KS; Park, EK; Shim, CK; Song, KW | 1 |
Castagné, V; Eveilleaux, E; Goineau, S; Lacaud, JL; Legrand, C | 1 |
Balakrishnan, P; Cho, HJ; Hahn, TW; Ko, HJ; Park, EK; Song, CK; Song, KW | 1 |
8 other study(ies) available for terfenadine and betadex
Article | Year |
---|---|
Resolution of terfenadine enantiomers by beta-cyclodextrin chiral stationary phase high-performance liquid chromatography.
Topics: beta-Cyclodextrins; Chromatography, High Pressure Liquid; Cyclodextrins; Hydrogen-Ion Concentration; Spectrophotometry, Ultraviolet; Stereoisomerism; Terfenadine | 1992 |
Resolution of terfenadine enantiomers by reversed phase-high performance liquid chromatography using beta-cyclodextrin as mobile phase additive.
Topics: beta-Cyclodextrins; Chromatography, High Pressure Liquid; Cyclodextrins; Histamine H1 Antagonists; Kinetics; Stereoisomerism; Terfenadine | 1996 |
Terfenadine-beta-Cyclodextrin inclusion complex with antihistaminic activity enhancement.
Topics: Algorithms; Animals; beta-Cyclodextrins; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Cyclodextrins; Excipients; Histamine H1 Antagonists; Histamine Release; Hydrogen-Ion Concentration; Kinetics; Male; Passive Cutaneous Anaphylaxis; Powders; Rats; Rats, Sprague-Dawley; Solubility; Spectrophotometry, Ultraviolet; Terfenadine | 2001 |
Determination of fexofenadine in tablets by capillary electrophoresis in free solution and in solution with cyclodextrins as analyte carriers.
Topics: Anti-Allergic Agents; beta-Cyclodextrins; Chemistry, Pharmaceutical; Drug Carriers; Electrolytes; Electrophoresis, Capillary; Histamine H1 Antagonists; Tablets; Terfenadine | 2005 |
Hydroxypropyl beta-cyclodextrins: a misleading vehicle for the in vitro hERG current assay.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; beta-Cyclodextrins; Biological Assay; Cisapride; Dose-Response Relationship, Drug; Electrophysiology; Ether-A-Go-Go Potassium Channels; Excipients; Gastrointestinal Agents; Histamine H1 Antagonists; Humans; Inhibitory Concentration 50; Myocytes, Cardiac; Piperidines; Potassium Channel Blockers; Pyridines; Solubility; Terfenadine; Time Factors | 2007 |
Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Intranasal; Animals; beta-Cyclodextrins; Cell Membrane Permeability; Cells, Cultured; Chitosan; Gels; Histamine H1 Antagonists, Non-Sedating; Humans; Poloxamer; Rabbits; Temperature; Terfenadine; Viscosity | 2011 |
In vitro safety cardiovascular pharmacology studies: impact of formulation preparation and analysis.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Action Potentials; beta-Cyclodextrins; Cardiovascular System; Chemistry, Pharmaceutical; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Excipients; Extracellular Fluid; HEK293 Cells; Humans; Patch-Clamp Techniques; Solubility; Terfenadine | 2013 |
Carbopol-incorporated thermoreversible gel for intranasal drug delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Acrylates; Adhesiveness; Administration, Intranasal; Animals; beta-Cyclodextrins; Biological Availability; Drug Delivery Systems; Gels; Histamine H1 Antagonists, Non-Sedating; Poloxamer; Rabbits; Rheology; Terfenadine; Tissue Distribution; Viscosity | 2015 |